Recent reports have demonstrated the association between type 1 diabetes mellitus (T1DM)
and increased morbidity and mortality rates during coronavirus disease (COVID-19) …

Objective This study aimed to determine the ability of retrospective cardiometabolic disease
staging (CMDS) and social determinants of health (SDoH) to predict COVID‐19 outcomes …

Obesity and type 2 diabetes mellitus are highly prevalent and increasing in the United States
among racial/ethnic minority groups. Type 2 diabetes mellitus, which is driven by many …

Background Inflammation is a predictor of severe complications in patients with COVID-19
infection under a variety of clinical settings. A few studies suggested that COVID-19 infection …

Background and aim This review aims to report the current status of COVID-19 among
people with diabetes, newly diagnosed diabetes, diabetic ketoacidosis, and programmatic …

The fast diffusion of the SARS-CoV-2 pandemic have called for an equally rapid evolution of
the therapeutic options. The Human recombinant monoclonal antibodies (mAbs) have …

Objectives We evaluated COVID‐19 outcomes in children and young adults with type 1
diabetes (T1D) to determine if those with comorbidities are more likely to experience severe …

The COVID-19 pandemic led to an unprecedented crisis, and early on, it has been shown
that diabetes is an important risk factor for complications and mortality in infected patients, as …

The outbreak of COVID-19, initially developed in China in early December 2019, has rapidly
spread to other countries and represents a public health emergency of international …

Vaccination against severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) is a
crucial step in ending the current worldwide pandemic. However, several particularly …